CYTX Share Price

Open 1.56 Change Price %
High 1.57 1 Day 0.00 0.00
Low 1.53 1 Week 0.05 3.33
Close 1.55 1 Month -0.03 -1.90
Volume 105087 1 Year 1.21 355.88
52 Week High 3.54
52 Week Low 0.00
CYTX Important Levels
Resistance 2 1.59
Resistance 1 1.57
Pivot 1.55
Support 1 1.53
Support 2 1.51
NASDAQ USA Most Active Stocks
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
MU 20.45 7.29%
MU 20.45 7.29%
MU 20.45 7.29%
More..
NASDAQ USA Top Gainers Stocks
LOCM 0.09 50.00%
ANTH 2.03 38.10%
EMKR 8.45 31.01%
MBLX 0.32 28.00%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
HTCO 8.00 23.08%
ATEA 1.95 21.88%
ATEA 1.95 21.88%
More..
NASDAQ USA Top Losers Stocks
DSTI 0.00 -100.00%
PTIX 0.00 -100.00%
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
More..

Cytori Therapeutics Inc (NASDAQ: CYTX)

CYTX Technical Analysis 2
As on 7th Dec 2016 CYTX Share Price closed @ 1.55 and we RECOMMEND Buy for LONG-TERM with Stoploss of 1.36 & Strong Sell for SHORT-TERM with Stoploss of 1.80 we also expect STOCK to react on Following IMPORTANT LEVELS.
CYTX Target for December
1st Target up-side 1.8
2nd Target up-side 1.97
3rd Target up-side 2.14
1st Target down-side 1.3
2nd Target down-side 1.13
3rd Target down-side 0.96
CYTX Other Details
Segment EQ
Market Capital 201966640.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.cytori.com
CYTX Address
CYTX
3020 Callan Road
San Diego, CA 92121
United States
Phone: 858-458-0900
Fax: 858-458-0994
Interactive Technical Analysis Chart Cytori Therapeutics Inc ( CYTX NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Cytori Therapeutics Inc
CYTX Business Profile
Cytori Therapeutics, Inc. develops cell therapies based on autologous adipose-derived stem and regenerative cells (ADRCs) to treat cardiovascular disease and repair soft tissue defects. The advanced therapeutic application in the Company's clinical pipeline is for cardiovascular disease. The Company�s products include Celbrush, Puregraft, and Cytori LipoBank. The Celbrush is available in the 10 milliliter and 3 milliliter sizes and is used in conjunction with a Soft-Ject Syringe in the corresponding size. The Puregraft System is developed for autologous fat grafting and aesthetic body contouring. The Puregraft System is available in two sizes: 250 milliliter, which processes 50-250 milliliter of tissue, and 850 milliliter, which processes 200-850 milliliter of tissue. The Cytori LipoBank is a GTP-compliant cryopreservation system that offers a long-term storage option for viable adipose tissue after a single liposuction.